UroGen Pharma (URGN) Asset Utilization Ratio (2018 - 2026)

UroGen Pharma (URGN) has 9 years of Asset Utilization Ratio data on file, last reported at 0.62 in Q1 2026.

• Quarterly Asset Utilization Ratio rose 79.59% year-over-year to 0.62 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.62 (up 79.59% YoY) and the FY2025 annual result came in at 0.45, up 15.92% from the prior year.
• Asset Utilization Ratio grew to 0.62 in Q1 2026, from 0.57 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.7 in Q2 2023 to a low of 0.31 in Q3 2024.
• A 5-year average of 0.46 and a median of 0.45 in 2024 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio soared 115.72% — and 2024, when it tumbled 49.38%.
• Tracing URGN's Asset Utilization Ratio over 5 years: stood at 0.49 in 2022, then slipped by 8.75% to 0.44 in 2023, then sank by 30.83% to 0.31 in 2024, then surged by 85.14% to 0.57 in 2025, then increased by 8.63% to 0.62 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.62 (Q1 2026), 0.57 (Q4 2025), and 0.49 (Q3 2025), per Business Quant data.